Skip to main content
. Author manuscript; available in PMC: 2020 Aug 18.
Published in final edited form as: J Med Genet. 2011 Feb 15;48(4):266–272. doi: 10.1136/jmg.2010.086538

Table 3.

Characteristics of probands and relatives who are known carriers of a CDKN2A mutation or with a predicted 25% or higher probability1 of being a carrier, by region of the proband and sex

Geographic region
and sex
Number
of
families
Number of
relatives with
≥ 25%
probability of
being a carrier1
Mean age
(range) at
diagnosis of
melanoma of
proband
Mean last known
age (range) of
relatives without
melanoma2
Number (%) of
relatives with
melanoma2
Mean age (range)
at diagnosis of
melanoma2 in
relatives
United Kingdom
 All 22 276 47 (24-72) 50 (0-97) 13 (5) 47 (17-75)
 Females - 119 46 (24-72) 49 (0-97) 6 (5) 43 (17-66)
 Males - 157 50 (41-67) 50 (6-88) 7 (4) 51 (39-75)
Australia
 All 13 143 34 (27-40) 57 (18-91) 20 (14) 47 (18-87)
 Females - 69 31 (27-37) 62 (26-91) 13 (19) 46 (18-84)
 Males - 74 36 (31-40) 53 (18-86) 7 (9) 50 (22-87)
 Brisbane 4 41 31 (27-36) 61 (26-91) 3 (7) 48 (22-67)
 Sydney 5 45 35 (29-40) 58 (18-85) 9 (20) 49 (18-87)
 Melbourne 4 57 34 (30-39) 55 (25-86) 8 (14) 45 (27-77)
1

Carrier probability was calculated from the genetic relatedness to known or inferred carriers, and not from melanoma status. The calculation assumes Mendel’s laws of inheritance, Hardy-Weinberg equilibrium and a population allele frequency of 0.001. Excludes 4 UK individuals whose sex was unknown.

2

Includes confirmed and unconfirmed reports of melanoma in relatives